SOM presents in the 5th Barcelona Healthcare Investment Forum 2011. The forum has become a meeting point between biotech start-up companies, medical devices and healthcare services and investors.
Category Archives: News
SOM presents its pipeline to the head of Strategic Research Alliances at Pfizer (UK). The meeting was held on 14 and 15 November at Biocat’s Barcelona headquarters.
SOM presents in the 4th ESADE BAN Investment Forum 2011 in Valencia (Spain). The Investment Forum is designed as a meeting point for those seeking investment opportunities and entrepreneurs with innovative projects looking to finance their business ventures during the initial stages.
SOM filed its 3rd international patent application for the treatment of transthyretin-related amyloidosis (TTR), a fatal and incurable disease designated as an “Orphan disease”.
A second private funding round for 1 Mill € has already been offered by the company to push forward its extensive pipeline of new indications.
SOM Biotech has been invited to present at The Drug Repositioning Conference which is going to take place in San Francisco on July 13-14, 2011. Presentations are only granted by invitation.
Laia Barbosa has joined SOM Biotech for a training period supported by the Barcelona Science Park program “Spend the summer at the Park !”. Laia is student of Pharmacy at the University of Barcelona.
SOM closes its first funding round with the investment of the venture capital firm Innova31 and six business angels. A second round is expected for late 2011.
Marc Centellas has joined SOM as a new Project Coordinator. Marc is BSc in Pharmacy and has been working for 10 years in the pharmaceutical industry mainly holding Regulatory and Quality positions.
Núria Reig has joined SOM team as Project Coordinator. Núria is PhD in Biochemical Sciences and has been working for more than 6 years in US and Switzerland, holding academic and biotech positions.